Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations.

× No keyword cloud information.

29 in total

Review 1. HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

Authors: Silke Wissing; Nicole L K Galloway; Warner C Greene
Journal: Mol Aspects Med Date: 2010-06-09

Review 2. HIV-1 evolution: frustrating therapies, but disclosing molecular mechanisms.

Authors: Atze T Das; Ben Berkhout
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2010-06-27 Impact factor: 6.237

3. Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors: Judd F Hultquist; Reuben S Harris
Journal: Future Virol Date: 2009-11-01 Impact factor: 1.831

4. Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistance.

Authors: Robert J Gifford; Soo-Yon Rhee; Nicolas Eriksson; Tommy F Liu; Mark Kiuchi; Amar K Das; Robert W Shafer
Journal: AIDS Date: 2008-03-30 Impact factor: 4.177

5. The impact of unprotected T cells in RNAi-based gene therapy for HIV-AIDS.

Authors: Elena Herrera-Carrillo; Ying Poi Liu; Ben Berkhout
Journal: Mol Ther Date: 2013-12-12 Impact factor: 11.454

Review 6. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors: Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal: J Mol Biol Date: 2013-11-02 Impact factor: 5.469

7. The HIV-1 Tat protein has a versatile role in activating viral transcription.

Authors: Atze T Das; Alex Harwig; Ben Berkhout
Journal: J Virol Date: 2011-07-13 Impact factor: 5.103

8. The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.

Authors: E Herrera-Carrillo; B Berkhout
Journal: Gene Ther Date: 2015-02-26 Impact factor: 5.250

Review 9. APOBECs and virus restriction.

Authors: Reuben S Harris; Jaquelin P Dudley
Journal: Virology Date: 2015-03-26 Impact factor: 3.616

10. Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.

Authors: Patric Jern; Rebecca A Russell; Vinay K Pathak; John M Coffin
Journal: PLoS Pathog Date: 2009-04-03 Impact factor: 6.823